Press Releases
-
Astoriom Appoints Will Edwards as Chief Executive Officer
Strategic appointment to support global scale-up of sample management operations
Jan 12, 2026
-
Hongene Biotech Announces Grant to Expand Global Access to mRNA Vaccine Raw Materials
Jan 12, 2026
-
Cellistic Launches Three New iPSC-based GMP Manufacturing Platforms to advance Immuno-Oncology and Regenerative Cell Therapies
Jan 12, 2026
-
Cycle Pharmaceuticals and Inceptua Group Expand the Free Goods Programme for Patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU) to Include Morocco and Egypt
Cycle and Inceptua have announced the expansion of their partnership to make NITYR® tablets available via a Free Goods Programme for eligible patients with HT-1 and AKU to include Morocco and Egypt.
Jan 11, 2026
-
Veeva and BioMarin Form Long-Term Strategic Partnership
Jan 7, 2026
-
Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics
Jan 8, 2026
-
LabConnect Establishes New Global Headquarters in Raleigh-Durham Area
LabConnect has established its new global headquarters in the Raleigh-Durham area to strategically align itself with the Research Triangle’s dense network of biotechnology and pharmaceutical partners. The new command center will house executive leadership and technology teams, overseeing an asset-light network of seven operational sites that support complex clinical trials across the globe. By moving to this hub, the company aims to accelerate innovation in drug development while aggressively scaling its local workforce in data science and scientific operations.
Jan 6, 2026
-
PharmaForceIQ Acquires Aktana to Deliver Unparalleled Cross-Functional Engagement Impact for Pharma
PharmaForceIQ has announced its acquisition of Aktana, aligning its cutting-edge digital orchestration platform with the industry’s premier AI-driven field Next-Best-Action (NBA) platform.
Jan 6, 2026
-
Biopharma PEG Expands Integrated PEGylated Protein Development Platform
Dec 23, 2025
-
Linus Health Adds Deep Clinical and Public Health Experience with Appointment of Julie Wood, MD, MPH, FAAFP, as Senior Medical Director, Clinician Engagement
Linus Health Appointments Julie Wood, MD, MPH, FAAFP, as Senior Medical Director, Clinician Engagement
Dec 14, 2025
-
Sanome announces two UK hospital partnerships to deploy AI-powered clinical intelligence for earlier infection detection
Dec 15, 2025
-
Neupulse launches first-of-its-kind wearable with the support of Ensera Design to help people living with Tourette Syndrome
Dec 14, 2025
-
ProPharma Expands Operations with New Office in Hyderabad
Modern workspace supports continued growth and innovation
Dec 10, 2025
-
eClinical Solutions Unveils AI Agents to Power the Next Era of Clinical Data Automation
Built directly into the elluminate ecosystem, the agents combine governed data with explainable intelligence to accelerate decisions
Dec 9, 2025
-
CluePoints Scoops Prestigious 2025 Scrip Award
CluePoints, provider of leading statistical and AI-driven software solutions, has won the ‘Best Contract Research Organization– Specialist Providers’ category at the 2025 Scrip Awards.
Dec 11, 2025
-
Advarra expands study collaboration solution, connecting leading clinical trial technology partners to simplify site access
New integrations with industry leaders in EDC, eConsent, IRT/RTSM, eCOA, payments, and patient engagement expands Advarra's connected ecosystem, giving sponsors, CROs, and research sites secure, centralized access to critical study technologies
Dec 9, 2025
-
Ansa Biotechnologies Appoints Geoff Hamilton as Chief Financial Officer and Chief Business Officer
Ansa Biotechnologies announced the appointment of Geoff Hamilton as Chief Financial Officer and Chief Business Officer.
Dec 8, 2025
-
ProPharma Welcomes Dan Ryan as President of Clinical Research Solutions
Strategic Structural Update Positions ProPharma As Market Leader
Dec 3, 2025
-
Quotient Sciences and Intrepid Labs form strategic partnership to accelerate AI-guided formulation development
Dec 3, 2025
-
Emerald Clinical Appoints Luke Gill as Vice President, Global Head of Oncology, Medical & Scientific Affairs
Accomplished biotech and CRO leader brings 25+ years of global oncology drug development and operational excellence to propel Emerald’s continued growth.
Dec 2, 2025






